ADAM-Mediated Signalling Pathways in Gastrointestinal Cancer Formation
Tumour growth is not solely driven by tumour cell-intrinsic mechanisms, but also depends on paracrine signals provided by the tumour micro-environment. These signals comprise cytokines and growth factors that are synthesized as trans-membrane proteins and need to be liberated by limited proteolysis...
Main Authors: | Neele Schumacher, Stefan Rose-John, Dirk Schmidt-Arras |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/14/5133 |
Similar Items
-
Regulation of Fibrotic Processes in the Liver by ADAM Proteases
by: Dirk Schmidt-Arras, et al.
Published: (2019-10-01) -
ADAM17: An Emerging Therapeutic Target for Lung Cancer
by: Mohamed I. Saad, et al.
Published: (2019-08-01) -
Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17
by: Rolake O. Alabi, et al.
Published: (2021-02-01) -
A Disintegrin and Metalloproteinase (ADAM) Family—Novel Biomarkers of Selected Gastrointestinal (GI) Malignancies?
by: Marta Łukaszewicz-Zając, et al.
Published: (2022-05-01) -
A Bispecific Inhibitor of the EGFR/ADAM17 Axis Decreases Cell Proliferation and Migration of EGFR-Dependent Cancer Cells
by: Abel Soto-Gamez, et al.
Published: (2020-02-01)